Tecan Annual Report
Tecan Annual Report

13  INFORMATION ACCORDING TO ARTICLE 663C OF THE SWISS CODE OF OBLIGATIONS

13.1  Significant shareholders

According to the information available to the Board of Directors, the following shareholders have reached or exceeded 5% of the share capital of Tecan Group Ltd:1

 

 

31.12.2021

31.12.2022

The Bank of New York Mellon SA/NV (BE)2

13.0%

9.6%

Chase Nominees Ltd., London (UK)2

6.8%

6.4%

Nortrust Nominees Ltd., London (UK)2

5.8%

5.6%

  1. Percentages are based on the actual share capital at the end of the reporting period.
  2. Nominee status - voting rights limited to 2% in accordance with article 5 of the atricles of incorporation.

13.2 SHARE AND OPTION OWNERSHIP OF THE BOARD OF DIRECTORS AND MANAGEMENT BOARD

For details of the employee participation plans please refer to note 12.4 of the consolidated financial statements.

 

13.2.1  Share and option ownership of the Board of Directors

 

Year

Total options

Total shares

Number

 

 

 

Dr. Lukas Braunschweiler (Chairman)

2021

1,297 

2022

 1,534 

Heinrich Fischer (Vice Chairman)

2021

17,217 

2022

17,347 

Myra Eskes
(since April 2022)1

2021

– 

2022

Dr. Oliver S. Fetzer

2021

 3,034 

2022

3,141

Dr. Karen Hübscher

2021

761

2022

868

Dr. Christa Kreuzburg

2021

159 

2022

Dr. Daniel R. Marshak

2021

536

2022

643

 

 

 

 

Balance at December 31, 2021

 

 23,004 

Balance at December 31, 2022

 

 – 

 23,533 

  1. Shares and share options in 2021 are not disclosed, because the member of the Board joined after year-end 2021.

13.2.2  Share and option ownership of the Management Board

 

Year

ESOP 20201

Total options

Total shares

Number

 

 

 

 

Strike price in CHF

 

236.0

 

 

Expiring in

 

2026

 

 

 

 

 

 

 

Dr. Achim von Leoprechting (CEO)

2021

 - 

 - 

5,309

2022

 - 

 - 

4,742

Tania Micki (CFO)

2021

 - 

 - 

1,873

2022

 - 

 - 

2,896

Ralf Griebel

2021

 - 

 - 

1,697

2022

 - 

 - 

2,503

Ulrich Kanter

2021

 - 

 - 

3,147

2022

 - 

 - 

2,620

Dr. Klaus Lun

2021

 - 

 - 

3,306

2022

 - 

 - 

5,053

Erik Norström

2021

 - 

 - 

2,690

2022

 - 

 - 

2,316

Ingrid Pürgstaller

2021

 98

 98

1,033

2022

 -

1,647

Andreas Wilhelm

2021

 - 

 - 

2,725

2022

 - 

 - 

2,282

Dr. Wael Yared

2021

 - 

 - 

2,773

2022

 - 

 - 

2,458

 

 

 

 

 

Balance at December 31, 2021

 

98 

 98 

24,553 

Balance at December 31, 2022

 

 -

26,517

  1. Vested options from employee share option plan 2020